FibroGen
Utility Patent Applications

Last updated:

List of all FibroGen patents 10 in total

Status Patent
Application
Utility: METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE External link
Filling date: 9 Sep 2025 Issue date: 2 Dec 2021
Application
Utility: METHODS OF TREATING ACUTE RESPIRATORY DISTRESS SYNDROME External link
Filling date: 9 Sep 2025 Issue date: 30 Sep 2021
Application
Utility: CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES External link
Filling date: 9 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: ENHANCED ERYTHROPOIESIS AND IRON METABOLISM External link
Filling date: 9 Sep 2025 Issue date: 22 Apr 2021
Application
Utility: ENHANCED ERYTHROPOIESIS AND IRON METABOLISM External link
Filling date: 9 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR External link
Filling date: 9 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS External link
Filling date: 9 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR External link
Filling date: 9 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF External link
Filling date: 9 Sep 2025 Issue date: 8 Aug 2019

Showing 1 to 10 of 10 patents.